(EXPE) Expedia - Overview
Sector: Consumer Cyclical | Industry: Travel Services | Exchange: NASDAQ (USA) | Market Cap: 26.179m USD | Total Return: 36.2% in 12m
Avg Turnover: 364M
EPS Trend: 99.0%
Qual. Beats: 3
Rev. Trend: 99.3%
Qual. Beats: 3
Warnings
Altman Z'' -1.23 < 1.0 - financial distress zone
Choppy
Tailwinds
Shakeout, Confidence, Garp
Expedia Group, Inc. (EXPE) is a global online travel company operating across three primary segments: B2C, B2B, and trivago. Its consumer portfolio includes high-traffic platforms such as Brand Expedia, Hotels.com, and Vrbo, which focuses on the alternative accommodation market. The company’s B2B division provides travel technology and inventory supply to corporate travel managers, airlines, and financial institutions.
The business model relies heavily on the agency and merchant frameworks, where the company earns commissions or markups on travel bookings. Unlike traditional hotel operators in the GICS Hotels, Resorts & Cruise Lines sub-industry, Expedia operates as an asset-light intermediary, generating revenue through transaction fees and performance-based advertising. Future growth is increasingly tied to the expansion of its loyalty programs and the integration of its multi-brand technology stack.
For a detailed breakdown of these operational shifts, you may find it useful to explore the data on ValueRay. Founded in 1996 and headquartered in Seattle, Expedia Group continues to compete in the highly fragmented global travel market against both direct suppliers and other metasearch platforms.
- Expansion of B2B travel technology partnerships accelerates high-margin revenue growth
- Competitive pressure from Airbnb and Booking Holdings impacts Vrbo market share
- Marketing spend efficiency and loyalty program integration determine overall operating margins
- Global travel demand fluctuations directly influence gross bookings and commission revenue
- Regulatory scrutiny on search engine dominance affects organic traffic and customer acquisition costs
| Net Income: 1.49b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 6.42 > 1.0 |
| NWC/Revenue: -34.34% < 20% (prev -36.16%; Δ 1.82% < -1%) |
| CFO/TA 0.18 > 3% & CFO 4.86b > Net Income 1.49b |
| Net Debt (-3.10b) to EBITDA (3.08b): -1.01 < 3 |
| Current Ratio: 0.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (121.8m) vs 12m ago -5.30% < -2% |
| Gross Margin: 90.27% > 18% (prev 0.90%; Δ 8.94k% > 0.5%) |
| Asset Turnover: 57.71% > 50% (prev 52.81%; Δ 4.91% > 0%) |
| Interest Coverage Ratio: 6.21 > 6 (EBITDA TTM 3.08b / Interest Expense TTM 352.0m) |
| A: -0.20 (Total Current Assets 14.2b - Total Current Liabilities 19.4b) / Total Assets 26.5b |
| B: 0.06 (Retained Earnings 1.63b / Total Assets 26.5b) |
| C: 0.08 (EBIT TTM 2.19b / Avg Total Assets 26.3b) |
| D: -0.66 (Book Value of Equity -16.3b / Total Liabilities 24.6b) |
| Altman-Z'' = -1.23 = CCC |
| DSRI: 1.05 (Receivables 5.20b/4.51b, Revenue 15.2b/13.8b) |
| GMI: 0.99 (GM 90.27% / 89.54%) |
| AQI: 0.97 (AQ_t 0.36 / AQ_t-1 0.38) |
| SGI: 1.10 (Revenue 15.2b / 13.8b) |
| TATA: -0.13 (NI 1.49b - CFO 4.86b) / TA 26.5b) |
| Beneish M = -3.07 (Cap -4..+1) = AA |
As of May 27, 2026, the stock is trading at USD 222.97 with a total of 1,596,501 shares traded.
Over the past week, the price has changed by +3.71%,
over one month by -9.07%,
over three months by +2.53% and
over the past year by +36.24%.
Expedia has received a consensus analysts rating of 3.76. Therefore, it is recommended to hold EXPE.
- StrongBuy: 13
- Buy: 3
- Hold: 20
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 286.3 | 28.4% |
P/E Trailing = 19.2686
P/E Forward = 11.0742
P/S = 1.7256
P/B = 45.45
P/EG = 0.7143
Revenue TTM = 15.2b USD
EBIT TTM = 2.19b USD
EBITDA TTM = 3.08b USD
Long Term Debt = 4.47b USD (from longTermDebt, last quarter)
Short Term Debt = 1.69b USD (from shortTermDebt, last fiscal year)
Debt = 4.94b USD (from shortLongTermDebtTotal, last quarter) + Leases 236.0m
Net Debt = -3.10b USD (calculated: Debt 4.94b - CCE 8.04b)
Enterprise Value = 23.1b USD (26.2b + Debt 4.94b - CCE 8.04b)
Interest Coverage Ratio = 6.21 (Ebit TTM 2.19b / Interest Expense TTM 352.0m)
EV/FCF = 4.92x (Enterprise Value 23.1b / FCF TTM 4.69b)
FCF Yield = 20.30% (FCF TTM 4.69b / Enterprise Value 23.1b)
FCF Margin = 30.89% (FCF TTM 4.69b / Revenue TTM 15.2b)
Net Margin = 9.81% (Net Income TTM 1.49b / Revenue TTM 15.2b)
Gross Margin = 90.27% ((Revenue TTM 15.2b - Cost of Revenue TTM 1.48b) / Revenue TTM)
Gross Margin QoQ = 89.00% (prev 90.25%)
Tobins Q-Ratio = 0.87 (Enterprise Value 23.1b / Total Assets 26.5b)
Interest Expense / Debt = 7.12% (Interest Expense 352.0m / Debt 4.94b)
Taxrate = 18.23% (290.0m / 1.59b)
NOPAT = 1.79b (EBIT 2.19b * (1 - 18.23%))
Current Ratio = 0.73 (Total Current Assets 14.2b / Total Current Liabilities 19.4b)
Debt / Equity = 8.58 (Debt 4.94b / totalStockholderEquity, last quarter 576.0m)
Debt / EBITDA = -1.01 (Net Debt -3.10b / EBITDA 3.08b)
Debt / FCF = -0.66 (Net Debt -3.10b / FCF TTM 4.69b)
Total Stockholder Equity = 1.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.66% (Net Income 1.49b / Total Assets 26.5b)
RoE = 147.6% (Net Income TTM 1.49b / Total Stockholder Equity 1.01b)
RoCE = 39.88% (EBIT 2.19b / Capital Employed (Equity 1.01b + L.T.Debt 4.47b))
RoIC = 21.71% (NOPAT 1.79b / Invested Capital 8.23b)
WACC = 10.57% (E(26.2b)/V(31.1b) * Re(11.47%) + D(4.94b)/V(31.1b) * Rd(7.12%) * (1-Tc(0.18)))
Discount Rate = 11.47% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -68.89 | Cagr: -7.30%
[DCF] Terminal Value 71.13% ; FCFF base≈3.99b ; Y1≈4.57b ; Y5≈6.73b
[DCF] Fair Price = 662.1 (EV 72.7b - Net Debt -3.10b = Equity 75.8b / Shares 114.5m; r=10.57% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.95 | EPS CAGR: 28.77% | SUE: 2.94 | # QB: 3
Revenue Correlation: 99.32 | Revenue CAGR: 7.32% | SUE: 0.98 | # QB: 3
EPS current Quarter (2026-06-30): EPS=5.19 | Chg30d=+4.21% | Revisions=+36% | Analysts=23
EPS next Quarter (2026-09-30): EPS=8.51 | Chg30d=-0.06% | Revisions=-45% | Analysts=23
EPS current Year (2026-12-31): EPS=19.76 | Chg30d=+2.39% | Revisions=+48% | GrowthEPS=+24.6% | GrowthRev=+8.6%
EPS next Year (2027-12-31): EPS=23.09 | Chg30d=+1.55% | Revisions=+19% | GrowthEPS=+16.8% | GrowthRev=+7.2%
[Analyst] Revisions Ratio: +48%